| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |